Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do viral chemokines modulate Kaposi's sarcoma?

D Dittmer1, D H Kedes

  • 1Department of Microbiology and Immunology, University of California, San Francisco, USA.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|July 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epstein-Barr virus microRNAs and lung cancer.

British journal of cancer·2011
Same author

Overview of the oral HIV/AIDS Research Alliance Program.

Advances in dental research·2011
Same author

Rhesus monkey rhadinovirus: a model for the study of KSHV.

Current topics in microbiology and immunology·2006
Same author

Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SIV-positive and SIV-negative rhesus macaques.

Journal of medical primatology·2004
Same author

Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus.

Journal of virology·2001
Same author

Capsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaherpesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirus.

Journal of virology·2001

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes viral chemokines that may drive tumor growth and affect HIV-1 infection. These viral chemokines play a role in the complex pathogenesis of Kaposi's sarcoma.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Kaposi's sarcoma (KS) is an angiogenic tumor frequently observed in HIV-infected individuals.
  • Epidemiological and molecular data strongly associate KS with a novel herpesvirus, Kaposi's sarcoma-associated herpesvirus (KSHV).
  • KSHV encodes cellular homologues, including viral macrophage inhibitory factor-1 alpha analogues (vMIP-I and vMIP-II).

Purpose of the Study:

  • To investigate the potential roles of KSHV-encoded viral chemokines (vMIP-I and vMIP-II) in the pathogenesis of Kaposi's sarcoma.
  • To understand how these viral chemokines influence neovascularization, HIV-1 infection, and immune responses in the context of KS.

Main Methods:

  • Analysis of KSHV-encoded genes, specifically vMIP-I and vMIP-II.
  • Review of existing molecular and epidemiological evidence linking KSHV to KS.

Related Experiment Videos

  • Examination of the potential functions of vMIP peptides in neovascularization, HIV-1 inhibition, and immune modulation.

    • Main Results:

    • KSHV encodes vMIP-I and vMIP-II, which are similar to human chemokines.
    • These viral chemokines are implicated in the pathogenesis of Kaposi's sarcoma.
    • vMIP peptides may promote neovascularization and modulate immune responses.

    Conclusions:

    • KSHV-encoded viral chemokines are significant factors in Kaposi's sarcoma development.
    • vMIP peptides contribute to KS pathogenesis by influencing angiogenesis and immune responses.
    • Further research into vMIPs could reveal therapeutic targets for KS and HIV-1 co-infection.